Skip to main content
x

CDC issues ACIP recommendations for the use of HPV vaccine

Rating
These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a quadrivalent human papillomavirus (HPV) vaccine licensed by the U.S. Food and Drug Administration on June 8, 2006. This report summarizes the epidemiology of HPV and associated diseases, describes the licensed HPV vaccine, and provides recommendations for its use for vaccination among females aged 9-26 years in the United States. March 2007.
Download Resource
AcipHPV032007.pdf (493.76 KB)
Categories